|
FTSJD2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.762100E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.749600E-02 |
| Normal-vs-Stage2 |
4.281700E-03 |
| Normal-vs-Stage3 |
1.756550E-04 |
| Normal-vs-Stage4 |
4.761500E-03 |
| Stage1-vs-Stage2 |
6.767700E-02 |
| Stage1-vs-Stage3 |
1.636320E-02 |
| Stage1-vs-Stage4 |
1.581790E-01 |
| Stage2-vs-Stage3 |
9.689400E-01 |
| Stage2-vs-Stage4 |
6.175000E-01 |
| Stage3-vs-Stage4 |
5.603400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.371700E-04 |
| Normal-vs-AfricanAmerican |
4.076400E-02 |
| Normal-vs-Asian |
4.121000E-01 |
| Caucasian-vs-AfricanAmerican |
8.353000E-01 |
| Caucasian-vs-Asian |
8.983600E-02 |
| AfricanAmerican-vs-Asian |
1.281620E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.95639999999564E-05 |
| Normal-vs-Female |
1.127810E-01 |
| Male-vs-Female |
2.182400E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.939800E-03 |
| Normal-vs-Age(41-60Yrs) |
1.212110E-02 |
| Normal-vs-Age(61-80Yrs) |
1.795390E-03 |
| Normal-vs-Age(81-100Yrs) |
8.177900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.481210E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.656400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.050200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.992600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.271200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.325600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.730100E-02 |
| Normal-vs-Grade 2 |
1.719670E-02 |
| Normal-vs-Grade 3 |
1.021830E-03 |
| Normal-vs-Grade 4 |
2.11259999999269E-05 |
| Grade 1-vs-Grade 2 |
4.768700E-04 |
| Grade 1-vs-Grade 3 |
9.53790000000065E-05 |
| Grade 1-vs-Grade 4 |
5.97649999999339E-05 |
| Grade 2-vs-Grade 3 |
1.920030E-01 |
| Grade 2-vs-Grade 4 |
6.962800E-03 |
| Grade 3-vs-Grade 4 |
1.252560E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.694200E-01 |
| Normal-vs-ccB subtype |
4.68750000004459E-06 |
| ccA subtype-vs-ccB subtype |
2.30390000000025E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.798500E-03 |
| Normal-vs-N1 |
1.315160E-01 |
| N0-vs-N1 |
4.994400E-01 |
|
|
